Petros Pharmaceuticals Inc (PTPI PINK) stock market data APIs
$0.0267
0(0%)
as of June 16, 2025
Try our APIs with
free plan!
Petros Pharmaceuticals Inc Financial Data Overview
Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary SaaS platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York.
Prev. Close
0.0267
Open
0.0306
High
0.034
Low
0.0244
52 wk Range
0.0247-16.25
Market Cap
841 K
Shares Outstanding
31 160 K
Revenue
5 112 K
EPS
-9.3743
Beta
1.763
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Petros Pharmaceuticals Inc data using free add-ons & libraries
Get Petros Pharmaceuticals Inc Fundamental Data
Petros Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 5 112 K
- EBITDA: -7 430 266
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-28
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Petros Pharmaceuticals Inc News
New
EXCLUSIVE: 'Prescription Erectile Dysfunction Market Could Triple If an ED Therapy Is Made Available OTC,' Petros Pharma President Says
EXCLUSIVE: 'Prescription Erectile Dysfunction Market Could Triple If an ED Therapy Is Made Available OTC,' Petros Pharma President Says Petros Pharmaceuticals Inc (NASDAQ:PTPI) is a pharmaceutical co...
The Urvan Group Issues Letter to AMMO Inc. Shareholders Regarding its Nomination of a Full Slate of Highly Qualified Candidates for Election to the Company’s Board of Directors
Delivers Overview of New Strategy for Leveraging AMMO’s Existing Assets and Evolving the Company into a Diversified, Growing and Profitable Ecommerce Powerhouse Highlights Long-Term Opportunity to ...
Petros Pharmaceuticals Responds to Fraudulent Press Release
NEW YORK, July 28, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, today confirmed that a press release issued on July ...
Petros Pharmaceuticals to be Acquired by Henry Crown and Company for $3.25 per share
Petros Pharmaceuticals to become a privately-owned company operating independently as part of Henry Crown and Company’s healthcare platform Petros Pharmaceuticals common shareholders will receive $...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
